Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03539783 · ClinicalTrials.gov registry record
Identifying PARDS Endotypes
A clinical trial of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult, sponsored by Children's Hospital Medical Center, Cincinnati.
- Completed
- Registry status
- 76
- Enrollment target
- 2
- Study locations
NCT03539783 is a study of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult that has completed, run by Children's Hospital Medical Center, Cincinnati. The registered enrollment target is 76 participants, below the 225-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (66% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03539783, a study of Respiratory Distress Syndrome and Respiratory Distress Syndrome, Adult, has completed, sponsored by Children's Hospital Medical Center, Cincinnati.
- COMPLETED
- Registry status
- 76 participants
- Enrollment target
- 2
- Study locations
Study Summary
Pediatric acute respiratory distress syndrome (PARDS) is a severe and diffuse lung injury that is a common cause of admission and mortality in the pediatric intensive care unit (PICU). PARDS can be secondary to many different causes, and there are few therapies that have been shown beneficial in PARDS. This study seeks to identify important PARDS subtypes using gene expression profiling of bronchial epithelial cells from control and PARDS subjects.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Respiratory epithelial cell brushing
Study Locations (2)
Ohio
- Cincinnati Children's Hospital Medical Center - Cincinnati
Pennsylvania
- Children's Hospital of Philadelphia - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 76 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2022-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03539783
The ClinicalTrials.gov registry entry for NCT03539783 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 76 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 225-participant average among 8 other Respiratory Distress Syndrome trials with a reported enrollment target (66% lower). The listed sponsor is Children's Hospital Medical Center, Cincinnati, which has 571 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Respiratory Distress Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Respiratory epithelial cell brushing is the first listed.
NCT03539783 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Ohio, Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT03539783 about?
NCT03539783 is a clinical study titled "Identifying PARDS Endotypes". Pediatric acute respiratory distress syndrome (PARDS) is a severe and diffuse lung injury that is a common cause of admission and mortality in the pediatric intensive care unit (PICU). PARDS can be secondary to many different causes, and there are few therapies that have been shown beneficial in PAR...
What is the current status of trial NCT03539783?
This trial is currently completed. The enrollment target is 76 participants. The study started on 2018-04-01. Estimated completion is 2022-09-05.
What conditions does trial NCT03539783 study?
This clinical trial studies the following conditions: Respiratory Distress Syndrome, Respiratory Distress Syndrome, Adult.
What interventions are being tested in trial NCT03539783?
The interventions under investigation include: Respiratory epithelial cell brushing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03539783?
This trial is sponsored by Children's Hospital Medical Center, Cincinnati, which has 571 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03539783 being conducted?
This trial has 2 study locations across Ohio, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Distress Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Non Inferiority Trial Investigating Surfactants Administered Via MIST
RECRUITING · Phase 4
-
Forced Oscillometry in Infants With Bronchopulmonary Dysplasia
RECRUITING
-
Safety and Efficacy of APC-0101 in Preterm Infants With Respiratory Distress Syndrome
RECRUITING · Phase 3
-
Spinal Cord Stimulation to Shorten Ventilator Dependence in ARDS Patients
RECRUITING · NA
-
The Budesonide in Babies (BiB) Trial
ACTIVE NOT RECRUITING · Phase 3
-
Phase I Study of Vasoactive Intestinal Peptide in Patients With Acute Respiratory Distress Syndrome and Sepsis
COMPLETED · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.